J.P. Morgan Private Wealth Advisors LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$623,154
-54.5%
54,329
+0.4%
0.00%
-71.4%
Q2 2023$1,369,929
-23.8%
54,126
-3.0%
0.01%
+75.0%
Q1 2023$1,797,640
+185.4%
55,810
+63.6%
0.00%
+300.0%
Q4 2022$629,874
-37.8%
34,121
-9.0%
0.00%
-66.7%
Q3 2022$1,013,000
+161.8%
37,507
+34.1%
0.00%
+200.0%
Q2 2022$387,000
-76.7%
27,978
-67.1%
0.00%
-75.0%
Q1 2022$1,660,000
-9.5%
85,145
-24.3%
0.00%0.0%
Q4 2021$1,835,000
-60.1%
112,444
-31.9%
0.00%
-63.6%
Q3 2021$4,600,000
+0.5%
165,106
+7.0%
0.01%
-8.3%
Q2 2021$4,575,000
+98.6%
154,350
+87.2%
0.01%
+71.4%
Q1 2021$2,304,000
+84.0%
82,445
+86.6%
0.01%
+75.0%
Q4 2020$1,252,000
-1.1%
44,194
-12.2%
0.00%
-20.0%
Q3 2020$1,266,000
-4.5%
50,348
-7.3%
0.01%
-16.7%
Q2 2020$1,326,000
+176.8%
54,290
+67.6%
0.01%
+100.0%
Q1 2020$479,000
+60.7%
32,388
+76.5%
0.00%
+200.0%
Q4 2019$298,000
+56.8%
18,350
+25.3%
0.00%0.0%
Q3 2019$190,000
+32.9%
14,642
+32.9%
0.00%0.0%
Q2 2019$143,00011,0170.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders